Abstract
Pulmonary neuroendocrine tumors (PNTs) comprise a spectrum of neoplasms, ranging from low grade carcinoids to the highly malignant small cell lung cancers. Several studies identified cytoskeleton protein Filamin A (FLNA) as determinant in cancer progression and metastasis. To date, the role of FLNA in PNTs aggressiveness and progression is still unknown. To address this question, we decided: i) to evaluate FLNA expression in PNTs ranging from typical carcinoids to small cell lung carcinomas; ii) to manipulate FLNA expression in order to assess its possible influence on cell proliferation, cell adhesion and migration in PNTs cell lines (H727 cells) and primary cultures; iii) to focus on the possible interaction between FLNA and Rap1, a small GTPase implicated in the regulation of cell polarity and migration. FLNA is highly expressed in PNTs with high malignant grade, this expression being the highest in small cell lung carcinomas. Interestingly, FLNA silencing reduces cyclin D1 levels in PNTs cells and H727 cells (−53±3 PPPPPP<0,01 vs C-siRNA). In conclusion, these results demonstrated that FLNA is involved in mediating PNT progression thus providing a possible diagnostic and therapeutic target.